Literature DB >> 20524570

Preoperative embolization in carotid body tumor surgery: is it required?

Daniel M Zeitler1, Joelle Glick, Gady Har-El.   

Abstract

OBJECTIVES: We compared estimated blood loss (EBL) in patients who underwent surgical excision of carotid body tumors (CBTs) after preoperative superselective angiography with embolization (PSE) with that in patients who underwent excision of CBTs without PSE.
METHODS: We performed a retrospective chart review of a consecutive case series in a single surgeon's practice within an academic tertiary care medical center. Twenty-five patients underwent surgical resection of a CBT from 1989 to 2009. From 1989 to 1996, 10 consecutive patients had PSE of the CBT, whereas the subsequent 15 patients (1996 to 2009) had no PSE. Demographic data including age, sex, and tumor size were collected. The EBL was obtained from intraoperative records and operative notes dictated at the time of surgery. Tumor size was based on preoperative radiographic measurements by a senior radiologist and the surgeon.
RESULTS: In the 10 patients with PSE, the mean age was 41 years (range, 22 to 72 years) and the mean tumor size was 4.8 cm (range, 2.9 to 8.3 cm). The mean EBL was 305 mL (range, 50 to 1,000 mL); 2 patients had an EBL of more than 400 mL. In the 15 patients without PSE, the mean age was 43.7 years (range, 20 to 75 years) and the mean tumor size was 4.4 cm (range, 2.8 to 7.9 cm). The mean EBL was 265.6 mL (range, 40 to 900 mL); 2 patients had an EBL of more than 400 mL. There were no significant differences between the 2 groups with regard to age, tumor size, or EBL.
CONCLUSIONS: Preoperative superselective angiography with embolization of a CBT does not lead to a significant reduction in intraoperative EBL.

Entities:  

Mesh:

Year:  2010        PMID: 20524570     DOI: 10.1177/000348941011900501

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  The use of internal carotid artery stenting in management of bilateral carotid body tumors.

Authors:  Masaya Konishi; Paolo Piazza; Seung-Ho Shin; Shailendra Sivalingam; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-04       Impact factor: 2.503

2.  Carotid Body Tumor Microenvironment.

Authors:  Jean-Paul Bryant; Shelly Wang; Toba Niazi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Carotid body tumor: a 25-year experience.

Authors:  Choakchai Metheetrairut; Chanticha Chotikavanich; Phawin Keskool; Nit Suphaphongs
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-08-02       Impact factor: 2.503

4.  Preoperative Super-Selective Embolization of Carotid Body Tumor and Multidisciplinary Approach.

Authors:  Mohamed Selim; Shahad H AlJehani; Alaa B Aljuhani; Amr Awad Albayomy
Journal:  Cureus       Date:  2021-01-23

5.  The effect of preoperative embolization on surgical outcomes for carotid body tumor resection.

Authors:  Robin Osofsky; Ross Clark; Jaideep Das Gupta; Nathan Boyd; Garth Olson; LeAnn Chavez; Sundeep Guliani; Mark Langsfeld; John Marek; Muhammad Ali Rana
Journal:  SAGE Open Med       Date:  2021-03-30

6.  Carotid paragangliomas. Alternatives for presurgical endovascular management.

Authors:  Angelica Maria Ruiz Gaviria; Edison Ernesto Nuñez Ovaez; Carlos Alberto Saldivar Rodea; Aldo Fabrizio Santini Sanchez
Journal:  Radiol Case Rep       Date:  2022-08-05

Review 7.  Head and neck paragangliomas: clinical and molecular genetic classification.

Authors:  Christian Offergeld; Christoph Brase; Svetlana Yaremchuk; Irina Mader; Hans Christian Rischke; Sven Gläsker; Kurt W Schmid; Thorsten Wiech; Simon F Preuss; Carlos Suárez; Tomasz Kopeć; Attila Patocs; Nelson Wohllk; Mahdi Malekpour; Carsten C Boedeker; Hartmut P H Neumann
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.